+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Home-Use Insulin Delivery Devices Market Research Report: By Type, Distribution Channel - Global Industry Analysis and Revenue Estimation to 2030

  • ID: 5464875
  • Report
  • August 2021
  • Region: Global
  • 226 Pages
  • Prescient & Strategic Intelligence Private Limited

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Biocon Limited
  • Eli Lilly and Company
  • Insulet Corporation
  • Medtronic plc
  • Novo Nordisk A/S
From $7,276.9 million in 2020, the size of the global home-use insulin delivery devices market will increase to $19,087.6 million in 2030, at a 10.2% CAGR between 2021 and 2030, according to the market research report.



The key drivers for the market are:


  • Rising Diabetes Incidence: Diabetes mellitus requires patients to administer artificial insulin since their pancreas stops producing the hormone (type 1) or the body can’t utilize the naturally produced insulin type 2). Thus, with the global diabetic population set to grow from 463 million in 2019 to around 700 million by 2045, as per the International Diabetes Federation (IDF), the market will grow.
  • Surging Geriatric Population: This is another strong propeller of the home-use insulin delivery devices market growth as the risk of diabetes is closely tied to age. Moreover, as per the Centers for Disease Control and Prevention (CDC), even if the growth of the diabetes incidence slows down, the overall incidence will still increase with the booming population of the elderly.

The home-use insulin delivery devices market was relatively unharmed by the COVID-19 pandemic as most of the pharmaceutical companies were operational. Moreover, since all non-COVID-related hospital departments were closed, diabetics turned to home-use insulin delivery devices for their daily dose.

The highest home-use insulin delivery devices market CAGR in the coming years, under the type segment, will be witnessed by insulin pens. Manufacturers of these devices are expanding their operations in countries with large diabetic populations, such as China and India. Additionally, insulin pens are being technologically advanced in order to help patients manage their diabetes better.

The pharmacies category held the largest share in the home-use insulin delivery devices market in the past, based on distribution channel. Since diabetes is a long-term health condition that requires an effective management regimen, most patients prefer registered pharmacies for purchasing such devices.

North America is the largest home-use insulin delivery devices market presently on account of the rising diabetes incidence and increasing awareness on its management and surging healthcare spending. Similarly, the obese population in the U.S., the larger of the two markets in the continent, stood at 93.3 million in 2015-2016, according to the CDC.

The major companies in the global home-use insulin delivery devices market are Tandem Diabetes Care Inc., Roche Holding AG, Biocon Limited, Insulet Corporation, Becton, Dickinson and Company, B. Braun Melsungen AG, Eli Lilly and Company, Sanofi, Novo Nordisk A/S, Wockhardt Limited, Medtronic plc, Ypsomed Holding AG, and Gulf Pharmaceutical Industries.
Frequently Asked Questions about the Home-Use Insulin Delivery Devices Market

What is the estimated value of the Home-Use Insulin Delivery Devices Market?

The Home-Use Insulin Delivery Devices Market was estimated to be valued at $7276.9 Million in 2020.

What is the growth rate of the Home-Use Insulin Delivery Devices Market?

The growth rate of the Home-Use Insulin Delivery Devices Market is 10.1%, with an estimated value of $19087.6 Million by 2030.

What is the forecasted size of the Home-Use Insulin Delivery Devices Market?

The Home-Use Insulin Delivery Devices Market is estimated to be worth $19087.6 Million by 2030.

Who are the key companies in the Home-Use Insulin Delivery Devices Market?

Key companies in the Home-Use Insulin Delivery Devices Market include Tandem Diabetes Care Inc., Biocon Limited, Roche Holding AG, Insulet Corporation, B. Braun Melsungen AG, Becton, Dickinson and Company, Eli Lilly and Company, Novo Nordisk A/S and Wockhardt Limited.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Biocon Limited
  • Eli Lilly and Company
  • Insulet Corporation
  • Medtronic plc
  • Novo Nordisk A/S

Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Analysis Period
1.3.1 Value
1.4 Market Size Breakdown by Segment
1.4.1 Market Segmentation by Type
1.4.2 Market Segmentation by Distribution Channel
1.4.3 Market Segmentation by Region
1.5 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.1.1 Paid
2.1.2 Unpaid
2.1.3 Publisher Database
2.2 Primary Research
2.2.1 Breakdown of Primary Research, by Region
2.2.2 Breakdown of Primary Research, by Industry Participant
2.2.3 Breakdown of Primary Research, by Designation
2.2.4 Breakdown of Primary Research, by Company Type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Currency Conversion Rates
2.6 Assumptions for the Study
2.7 Notes & Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
4.1 Global Human Insulin Market – The Parent Market
4.2 Prevalence of Diabetes
4.2.1 Global
4.2.2 North America and Caribbean
Chapter 5. Definition of Market Segments
5.1 By Type
5.1.1 Insulin Syringes
5.1.2 Insulin Pens
5.1.2.1 Reusable
5.1.2.2 Disposable
5.1.3 Insulin Pumps
5.1.3.1 External/tethered pumps
5.1.3.2 Patch pumps
5.1.4 Others
5.2 By Distribution Channel
5.2.1 Pharmacies
5.2.2 E-Commerce
5.2.3 Diabetes Clinics/Centers
Chapter 6. Industry Outlook
6.1 Market Dynamics
6.1.1 Trends
6.1.1.1 Surge in usage of insulin delivery devices
6.1.1.2 Growing significance of home infusion therapy for diabetes treatment
6.1.2 Drivers
6.1.2.1 Surging aging population
6.1.2.2 Technological advancements in insulin delivery devices
6.1.2.3 Increasing exposure of population to key risk factors for diabetes
6.1.2.4 Increasing prevalence of diabetes
6.1.3 Impact Analysis of Drivers on Market Forecast
6.1.4 Restraints
6.1.4.1 Stringent regulatory requirements
6.1.4.2 Complex manufacturing of syringes
6.1.4.3 High risk of breakage
6.1.5 Impact Analysis of Restraints on Market Forecast
6.1.6 Opportunities
6.1.6.1 Increasing awareness on diabetes management
6.2 Impact of COVID-19
6.3 Porter’s Five Forces Analysis
6.3.1 Bargaining Power of Buyers
6.3.2 Bargaining Power of Suppliers
6.3.3 Intensity of Rivalry
6.3.4 Threat of New Entrants
6.3.5 Threat of Substitutes
Chapter 7. Global Market Size and Forecast
7.1 Overview
7.2 Market Revenue, by Type (2015–2030)
7.2.1 Insulin Pens Market Revenue, by Type (2015–2030)
7.2.2 Insulin Pumps Market Revenue, by Type (2015–2030)
7.3 Market Revenue, by Distribution Channel (2015–2030)
7.4 Market Revenue, by Region (2015–2030)
Chapter 8. North America Market Size and Forecast
8.1 Overview
8.2 Market Revenue, by Type (2015–2030)
8.2.1 Insulin Pens Market Revenue, by Type (2015–2030)
8.2.2 Insulin Pumps Market Revenue, by Type (2015–2030)
8.3 Market Revenue, by Distribution Channel (2015–2030)
8.4 Market Revenue, by Country (2015–2030)
Chapter 9. Europe Market Size and Forecast
9.1 Overview
9.2 Market Revenue, by Type (2015–2030)
9.2.1 Insulin Pens Market Revenue, by Type (2015–2030)
9.2.2 Insulin Pumps Market Revenue, by Type (2015–2030)
9.3 Market Revenue, by Distribution Channel (2015–2030)
9.4 Market Revenue, by Country (2015–2030)
Chapter 10. APAC Market Size and Forecast
10.1 Overview
10.2 Market Revenue, by Type (2015–2030)
10.2.1 Insulin Pens Market Revenue, by Type (2015–2030)
10.2.2 Insulin Pumps Market Revenue, by Type (2015–2030)
10.3 Market Revenue, by Distribution Channel (2015–2030)
10.4 Market Revenue, by Country (2015–2030)
Chapter 11. LATAM Market Size and Forecast
11.1 Overview
11.2 Market Revenue, by Type (2015–2030)
11.2.1 Insulin Pens Market Revenue, by Type (2015–2030)
11.2.2 Insulin Pumps Market Revenue, by Type (2015–2030)
11.3 Market Revenue, by Distribution Channel (2015–2030)
11.4 Market Revenue, by Country (2015–2030)
Chapter 12. MEA Market Size and Forecast
12.1 Overview
12.2 Market Revenue, by Type (2015–2030)
12.2.1 Insulin Pens Market Revenue, by Type (2015–2030)
12.2.2 Insulin Pumps Market Revenue, by Type (2015–2030)
12.3 Market Revenue, by Distribution Channel (2015–2030)
12.4 Market Revenue, by Country (2015–2030)
Chapter 13. U.S. Market Size and Forecast
13.1 Overview
13.2 Market Revenue, by Type (2015–2030)
13.2.1 Insulin Pens Market Revenue, by Type (2015–2030)
13.2.2 Insulin Pumps Market Revenue, by Type (2015–2030)
13.3 Market Revenue, by Distribution Channel (2015–2030)
Chapter 14. Germany Market Size and Forecast
14.1 Overview
14.2 Market Revenue, by Type (2015–2030)
14.2.1 Insulin Pens Market Revenue, by Type (2015–2030)
14.2.2 Insulin Pumps Market Revenue, by Type (2015–2030)
14.3 Market Revenue, by Distribution Channel (2015–2030)
Chapter 15. France Market Size and Forecast
15.1 Overview
15.2 Market Revenue, by Type (2015–2030)
15.2.1 Insulin Pens Market Revenue, by Type (2015–2030)
15.2.2 Insulin Pumps Market Revenue, by Type (2015–2030)
15.3 Market Revenue, by Distribution Channel (2015–2030)
Chapter 16. U.K. Market Size and Forecast
16.1 Overview
16.2 Market Revenue, by Type (2015–2030)
16.2.1 Insulin Pens Market Revenue, by Type (2015–2030)
16.2.2 Insulin Pumps Market Revenue, by Type (2015–2030)
16.3 Market Revenue, by Distribution Channel (2015–2030)
Chapter 17. Italy Market Size and Forecast
17.1 Overview
17.2 Market Revenue, by Type (2015–2030)
17.2.1 Insulin Pens Market Revenue, by Type (2015–2030)
17.2.2 Insulin Pumps Market Revenue, by Type (2015–2030)
17.3 Market Revenue, by Distribution Channel (2015–2030)
Chapter 18. Spain Market Size and Forecast
18.1 Overview
18.2 Market Revenue, by Type (2015–2030)
18.2.1 Insulin Pens Market Revenue, by Type (2015–2030)
18.2.2 Insulin Pumps Market Revenue, by Type (2015–2030)
18.3 Market Revenue, by Distribution Channel (2015–2030)
Chapter 19. Japan Market Size and Forecast
19.1 Overview
19.2 Market Revenue, by Type (2015–2030)
19.2.1 Insulin Pens Market Revenue, by Type (2015–2030)
19.2.2 Insulin Pumps Market Revenue, by Type (2015–2030)
19.3 Market Revenue, by Distribution Channel (2015–2030)
Chapter 20. Competitive Landscape
20.1 Global Home-Use Insulin Delivery Devices Market Share Analysis of Key Players (2020)
20.2 List of Market Players and Their Offerings
20.3 Recent Strategic Developments in the Market
20.3.1 Product Launches and Approvals
20.3.2 Partnerships
20.3.3 Mergers and Acquisitions
20.3.4 Other Developments
Chapter 21. Company Profiles
21.1 Tandem Diabetes Care Inc.
21.1.1 Business Overview
21.1.2 Product and Service Offerings
21.1.3 Key Financial Summary
21.2 Biocon Limited
21.2.1 Business Overview
21.2.2 Product and Service Offerings
21.2.3 Key Financial Summary
21.3 Roche Holding AG
21.3.1 Business Overview
21.3.2 Product and Service Offerings
21.3.3 Key Financial Summary
21.4 Insulet Corporation
21.4.1 Business Overview
21.4.2 Product and Service Offerings
21.4.3 Key Financial Summary
21.5 B. Braun Melsungen AG
21.5.1 Business Overview
21.5.2 Product and Service Offerings
21.5.3 Key Financial Summary
21.6 Becton, Dickinson and Company
21.6.1 Business Overview
21.6.2 Product and Service Offerings
21.6.3 Key Financial Summary
21.7 Eli Lilly and Company
21.7.1 Business Overview
21.7.2 Product and Service Offerings
21.7.3 Key Financial Summary
21.8 Novo Nordisk A/S
21.8.1 Business Overview
21.8.2 Product and Service Offerings
21.8.3 Key Financial Summary
21.9 Sanofi
21.9.1 Business Overview
21.9.2 Product and Service Offerings
21.9.3 Key Financial Summary
21.10 Wockhardt Limited
21.10.1 Business Overview
21.10.2 Product and Service Offerings
21.10.3 Key Financial Summary
21.11 Ypsomed Holding AG
21.11.1 Business Overview
21.11.2 Product and Service Offerings
21.11.3 Key Financial Summary
21.12 Medtronic plc
21.12.1 Business Overview
21.12.2 Product and Service Offerings
21.12.3 Key Financial Summary
21.13 Gulf Pharmaceutical Industries
21.13.1 Business Overview
21.13.2 Product and Service Offerings
21.13.3 Key Financial Summary
Chapter 22. Appendix
22.1 Abbreviations
22.2 Sources and References
22.3 Related Reports
LIST OF TABLES
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 GLOBAL HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 5 GLOBAL HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 6 GLOBAL HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 7 GLOBAL INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 8 GLOBAL INSULIN PENS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 9 GLOBAL INSULIN PENS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 10 GLOBAL INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 11 GLOBAL INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 12 GLOBAL INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 13 GLOBAL HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2020)
TABLE 14 GLOBAL HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2021–2025)
TABLE 15 GLOBAL HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2026–2030)
TABLE 16 GLOBAL HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY REGION, $M (2015–2020)
TABLE 17 GLOBAL HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY REGION, $M (2021–2025)
TABLE 18 GLOBAL HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY REGION, $M (2026–2030)
TABLE 19 NORTH AMERICA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 20 NORTH AMERICA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 21 NORTH AMERICA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 22 NORTH AMERICA INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 23 NORTH AMERICA INSULIN PENS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 24 NORTH AMERICA INSULIN PENS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 25 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 26 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 27 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 28 NORTH AMERICA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2020)
TABLE 29 NORTH AMERICA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2021–2025)
TABLE 30 NORTH AMERICA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2026–2030)
TABLE 31 NORTH AMERICA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY COUNTRY, $M (2015–2020)
TABLE 32 NORTH AMERICA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY COUNTRY, $M (2021–2025)
TABLE 33 NORTH AMERICA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY COUNTRY, $M (2026–2030)
TABLE 34 EUROPE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 35 EUROPE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 36 EUROPE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 37 EUROPE INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 38 EUROPE INSULIN PENS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 39 EUROPE INSULIN PENS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 40 EUROPE INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 41 EUROPE INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 42 EUROPE INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 43 EUROPE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2020)
TABLE 44 EUROPE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2021–2025)
TABLE 45 EUROPE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2026–2030)
TABLE 46 EUROPE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY COUNTRY, $M (2015–2020)
TABLE 47 EUROPE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY COUNTRY, $M (2021–2025)
TABLE 48 EUROPE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY COUNTRY, $M (2026–2030)
TABLE 49 APAC HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 50 APAC HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 51 APAC HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 52 APAC INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 53 APAC INSULIN PENS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 54 APAC INSULIN PENS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 55 APAC INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 56 APAC INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 57 APAC INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 58 APAC HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2020)
TABLE 59 APAC HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2021–2025)
TABLE 60 APAC HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2026–2030)
TABLE 61 APAC HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY COUNTRY, $M (2015–2020)
TABLE 62 APAC HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY COUNTRY, $M (2021–2025)
TABLE 63 APAC HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY COUNTRY, $M (2026–2030)
TABLE 64 LATAM HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 65 LATAM HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 66 LATAM HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 67 LATAM INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 68 LATAM INSULIN PENS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 69 LATAM INSULIN PENS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 70 LATAM INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 71 LATAM INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 72 LATAM INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 73 LATAM HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2020)
TABLE 74 LATAM HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2021–2025)
TABLE 75 LATAM HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2026–2030)
TABLE 76 LATAM HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY COUNTRY, $M (2015–2020)
TABLE 77 LATAM HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY COUNTRY, $M (2021–2025)
TABLE 78 LATAM HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY COUNTRY, $M (2026–2030)
TABLE 79 MEA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 80 MEA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 81 MEA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 82 MEA INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 83 MEA INSULIN PENS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 84 MEA INSULIN PENS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 85 MEA INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 86 MEA INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 87 MEA INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 88 MEA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2020)
TABLE 89 MEA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2021–2025)
TABLE 90 MEA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2026–2030)
TABLE 91 MEA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY COUNTRY, $M (2015–2020)
TABLE 92 MEA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY COUNTRY, $M (2021–2025)
TABLE 93 MEA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY COUNTRY, $M (2026–2030)
TABLE 94 U.S. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 95 U.S. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 96 U.S. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 97 U.S. INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 98 U.S. INSULIN PENS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 99 U.S. INSULIN PENS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 100 U.S. INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 101 U.S. INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 102 U.S. INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 103 U.S. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2020)
TABLE 104 U.S. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2021–2025)
TABLE 105 U.S. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2026–2030)
TABLE 106 GERMANY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 107 GERMANY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 108 GERMANY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 109 GERMANY INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 110 GERMANY INSULIN PENS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 111 GERMANY INSULIN PENS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 112 GERMANY INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 113 GERMANY INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 114 GERMANY INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 115 GERMANY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2020)
TABLE 116 GERMANY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2021–2025)
TABLE 117 GERMANY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2026–2030)
TABLE 118 FRANCE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 119 FRANCE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 120 FRANCE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 121 FRANCE INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 122 FRANCE INSULIN PENS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 123 FRANCE INSULIN PENS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 124 FRANCE INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 125 FRANCE INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 126 FRANCE INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 127 FRANCE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2020)
TABLE 128 FRANCE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2021–2025)
TABLE 129 FRANCE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2026–2030)
TABLE 130 U.K. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 131 U.K. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 132 U.K. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 133 U.K. INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 134 U.K. INSULIN PENS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 135 U.K. INSULIN PENS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 136 U.K. INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 137 U.K. INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 138 U.K. INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 139 U.K. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2020)
TABLE 140 U.K. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2021–2025)
TABLE 141 U.K. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2026–2030)
TABLE 142 ITALY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 143 ITALY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 144 ITALY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 145 ITALY INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 146 ITALY INSULIN PENS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 147 ITALY INSULIN PENS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 148 ITALY INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 149 ITALY INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 150 ITALY INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 151 ITALY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2020)
TABLE 152 ITALY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2021–2025)
TABLE 153 ITALY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2026–2030)
TABLE 154 SPAIN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 155 SPAIN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 156 SPAIN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 157 SPAIN INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 158 SPAIN INSULIN PENS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 159 SPAIN INSULIN PENS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 160 SPAIN INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 161 SPAIN INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 162 SPAIN INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 163 SPAIN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2020)
TABLE 164 SPAIN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2021–2025)
TABLE 165 SPAIN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2026–2030)
TABLE 166 JAPAN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 167 JAPAN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 168 JAPAN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 169 JAPAN INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 170 JAPAN INSULIN PENS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 171 JAPAN INSULIN PENS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 172 JAPAN INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2020)
TABLE 173 JAPAN INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2021–2025)
TABLE 174 JAPAN INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2026–2030)
TABLE 175 JAPAN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2020)
TABLE 176 JAPAN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2021–2025)
TABLE 177 JAPAN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2026–2030)
TABLE 178 LIST OF MARKET PLAYERS AND THEIR OFFERINGS
TABLE 179 TANDEM DIABETES CARE INC. – AT A GLANCE
TABLE 180 TANDEM DIABETES CARE INC. – KEY FINANCIAL SUMMARY
TABLE 181 BIOCON LIMITED – AT A GLANCE
TABLE 182 BIOCON LIMITED – KEY FINANCIAL SUMMARY
TABLE 183 ROCHE HOLDING AG – AT A GLANCE
TABLE 184 ROCHE HOLDING AG – KEY FINANCIAL SUMMARY
TABLE 185 INSULET CORPORATION – AT A GLANCE
TABLE 186 INSULET CORPORATION – KEY FINANCIAL SUMMARY
TABLE 187 B. BRAUN MELSUNGEN AG – AT A GLANCE
TABLE 188 B. BRAUN MELSUNGEN AG – KEY FINANCIAL SUMMARY
TABLE 189 BECTON, DICKINSON AND COMPANY – AT A GLANCE
TABLE 190 BECTON, DICKINSON AND COMPANY – KEY FINANCIAL SUMMARY
TABLE 191 ELI LILLY AND COMPANY – AT A GLANCE
TABLE 192 ELI LILLY AND COMPANY – KEY FINANCIAL SUMMARY
TABLE 193 NOVO NORDISK A/S – AT A GLANCE
TABLE 194 NOVO NORDISK A/S – KEY FINANCIAL SUMMARY
TABLE 195 SANOFI – AT A GLANCE
TABLE 196 SANOFI – KEY FINANCIAL SUMMARY
TABLE 197 WOCKHARDT LIMITED – AT A GLANCE
TABLE 198 WOCKHARDT LIMITED – KEY FINANCIAL SUMMARY
TABLE 199 YPSOMED HOLDING AG – AT A GLANCE
TABLE 200 YPSOMED HOLDING AG – KEY FINANCIAL SUMMARY
TABLE 201 MEDTRONIC PLC – AT A GLANCE
TABLE 202 MEDTRONIC PLC – KEY FINANCIAL SUMMARY
TABLE 203 GULF PHARMACEUTICAL INDUSTRIES – AT A GLANCE
TABLE 204 GULF PHARMACEUTICAL INDUSTRIES – KEY FINANCIAL SUMMARY
LIST OF FIGURES
FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT
FIG 2 RESEARCH METHODOLOGY
FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION
FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY INDUSTRY PARTICIPANT
FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION
FIG 6 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
FIG 7 DATA TRIANGULATION APPROACH
FIG 8 CURRENCY CONVERSION RATES FOR USD (2020)
FIG 9 GLOBAL HOME-USE INSULIN DELIVERY DEVICES MARKET SUMMARY
FIG 10 GLOBAL HUMAN INSULIN MARKET, $B (2015–2019)
FIG 11 GLOBAL PREVALENCE OF DIABETES, MILLION CASES (2019, 2030, AND 2045)
FIG 12 PREVALENCE OF DIABETES IN NORTH AMERICA AND CARIBBEAN, MILLION CASES (2019, 2030, AND 2045)
FIG 13 NUMBER OF PEOPLE AGED 20-79 YEARS SUFFERING FROM DIABETES, IN MILLIONS (2019, 2030, & 2045)
FIG 14 BARGAINING POWER OF BUYERS
FIG 15 BARGAINING POWER OF SUPPLIERS
FIG 16 INTENSITY OF RIVALRY
FIG 17 THREAT OF NEW ENTRANTS
FIG 18 THREAT OF SUBSTITUTES
FIG 19 GLOBAL HOME-USE INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIG 20 GLOBAL HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 21 GLOBAL INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 22 GLOBAL INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 23 GLOBAL HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2030)
FIG 24 NORTH AMERICA HOME-USE INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIG 25 NORTH AMERICA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 26 NORTH AMERICA INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 27 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 28 NORTH AMERICA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2030)
FIG 29 EUROPE HOME-USE INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIG 30 EUROPE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 31 EUROPE INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 32 EUROPE INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 33 EUROPE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2030)
FIG 34 APAC HOME-USE INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIG 35 APAC HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 36 APAC INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 37 APAC INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 38 APAC HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2030)
FIG 39 LATAM HOME-USE INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIG 40 LATAM HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 41 LATAM INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 42 LATAM INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 43 LATAM HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2030)
FIG 44 MEA HOME-USE INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIG 45 MEA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 46 MEA INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 47 MEA INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 48 MEA HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2030)
FIG 49 U.S. HOME-USE INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIG 50 U.S. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 51 U.S. INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 52 U.S. INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 53 U.S. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2030)
FIG 54 GERMANY HOME-USE INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIG 55 GERMANY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 56 GERMANY INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 57 GERMANY INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 58 GERMANY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2030)
FIG 59 FRANCE HOME-USE INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIG 60 FRANCE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 61 FRANCE INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 62 FRANCE INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 63 FRANCE HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2030)
FIG 64 U.K. HOME-USE INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIG 65 U.K. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 66 U.K. INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 67 U.K. INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 68 U.K. HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2030)
FIG 69 ITALY HOME-USE INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIG 70 ITALY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 71 ITALY INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 72 ITALY INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 73 ITALY HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2030)
FIG 74 SPAIN HOME-USE INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIG 75 SPAIN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 76 SPAIN INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 77 SPAIN INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 78 SPAIN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2030)
FIG 79 JAPAN HOME-USE INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIG 80 JAPAN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 81 JAPAN INSULIN PENS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 82 JAPAN INSULIN PUMPS MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 83 JAPAN HOME-USE INSULIN DELIVERY DEVICES MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015–2030)
FIG 84 GLOBAL HOME-USE INSULIN DELIVERY DEVICES MARKET SHARE ANALYSIS OF KEY PLAYERS (2020)
FIG 85 TANDEM DIABETES CARE INC. – REVENUE SPLIT BY PRODUCT AND GEOGRAPHY (2020)
FIG 86 BIOCON LIMITED – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 87 ROCHE HOLDING AG – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 88 B. BRAUN MELSUNGEN AG – REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2020)
FIG 89 BECTON, DICKINSON AND COMPANY – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 90 ELI LILLY AND COMPANY – REVENUE SPLIT BY PRODUCT AND GEOGRAPHY (2020)
FIG 91 NOVO NORDISK A/S – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 92 SANOFI – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 93 WOCKHARDT LIMITED – REVENUE SPLIT BY GEOGRAPHY (2020)
FIG 94 YPSOMED HOLDING AG – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 95 MEDTRONIC PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)"
Note: Product cover images may vary from those shown
  • Tandem Diabetes Care Inc.
  • Biocon Limited
  • Roche Holding AG
  • Insulet Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Sanofi
  • Wockhardt Limited
  • Ypsomed Holding AG
  • Medtronic plc
  • Gulf Pharmaceutical Industries
Note: Product cover images may vary from those shown

Loading
LOADING...